Inheritest 500 PLUS Panel Integrated Genetics Westborough LabCorp United States | 287 | 578 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 137 Male Natera, Inc. United States | 130 | 133 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 4 Male Plus TSE Natera, Inc. United States | 3 | 3 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 3 Male Natera, Inc. United States | 2 | 2 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 14 Male plus TSE Natera, Inc. United States | 12 | 14 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 14 Male Natera, Inc. United States | 12 | 13 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 3 Plus TSE Natera, Inc. United States | 3 | 3 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 4 Male Natera, Inc. United States | 2 | 2 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Horizon 274 Male Natera, Inc. United States | 244 | 254 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
|
Super Panel Plus NxGen MDx United States | 116 | 117 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Spinal Muscle Atrophy NxGen MDx United States | 1 | 2 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
|
Essential Panel NxGen MDx United States | 3 | 4 | - D Deletion/duplication analysis
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 14 Natera, Inc. United States | 15 | 15 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 plus TSE Natera, Inc. United States | 103 | 107 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 Natera, Inc. United States | 28 | 28 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 106 Natera, Inc. United States | 103 | 106 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 27 plus TSE Natera, Inc. United States | 28 | 29 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Plus TSE Natera, Inc. United States | 265 | 275 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 274 Natera, Inc. United States | 265 | 274 | - E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|
Horizon 137 plus TSE Natera, Inc. United States | 135 | 138 | - E Enzyme assay
- E Sequence analysis of select exons
- C Sequence analysis of the entire coding region
- T Targeted variant analysis
|